Although NT administration has been tested as a potential therapy in peripheral neuropathies (e.g., NGF to treat diabetic neuropathy), those trials were complicated by dose-limiting pleiotropic effects, such as pain.42 The gene discussed is NGF; the disease is diabetic neuropathy.